Pandemic News and Research

RSS

A pandemic is a global disease outbreak. During a pandemic, transmission can be anticipated in the workplace, not only from patient to workers in health care settings, but also among co-workers in general work settings. A pandemic would cause high levels of illness, death, social disruption, and economic loss. Everyday life would be disrupted because so many people in so many places become seriously ill at the same time. Impacts could range from school and business closings to the interruption of basic services such as public transportation and food delivery.

Study uncovers a novel promising target for diabetes treatment

Researchers have discovered a novel and druggable insulin inhibitory receptor, named inceptor. The latest study from Helmholtz Zentrum Muenchen, the Technical University of Munich and the German Center for Diabetes Research is a significant milestone for diabetes research as the scientific community celebrates 100 years of insulin and 50 years of insulin receptor discovery.

27 Jan 2021

New model could help clinicians to safely allow two patients to share a single ventilator

As Covid-19 continues to put pressure on healthcare providers around the world, engineers at the University of Bath have published a mathematical model that could help clinicians to safely allow two people to share a single ventilator.

27 Jan 2021

COVID-19 mortality rates higher in pregnant women than in similarly aged individuals

Contracting COVID-19 while pregnant can have deadly consequences for the mother, a new study published today in American Journal of Obstetrics and Gynecology shows.

27 Jan 2021

Anakinra shows therapeutic potential in critically ill COVID-19 patients

A team of international scientists recently conducted an open-level clinical trial to investigate the effects of personalized immunotherapy on critically ill COVID-19 patients.

27 Jan 2021

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

As the U.S. continues to grapple with surging cases and the complex logistics of mass vaccination, is the country in a position to fully re-open its schools for in-person learning? Researchers at the Centers for Disease Control and Prevention (CDC) think so – notwithstanding a few very important caveats.

27 Jan 2021

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Heart disease remains the leading cause of death worldwide, according to the American Heart Association's Heart Disease and Stroke Statistics -- 2021 Update, published today in the Association's flagship journal Circulation, and experts warn that the broad influence of the COVID-19 pandemic will likely continue to extend that ranking for years to come.

27 Jan 2021

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Researchers have described the potential of the drug spironolactone, a potassium-sparing diuretic, and anti-androgen, in preventing or alleviating the severity of COVID-19 pneumonia, and in preventing pulmonary fibrosis.

27 Jan 2021

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

It was the end of April — just as the U.S. confirmed its millionth covid-19 case and 50,000 deaths — when White House adviser Dr. Anthony Fauci announced "highly significant" news about a drug called remdesivir.

27 Jan 2021

What do we know about the SARS-CoV-2 vaccines so far?

A new study surveys what we know so far about SARS-CoV-2 vaccine candidates from advanced clinical trials.

27 Jan 2021

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

A Purdue University-affiliated startup is receiving national support to pursue a strategy to treat severe COVID-19 cases and possible future outbreaks involving other viruses.

27 Jan 2021

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Allarity Therapeutics of Hørsholm, Denmark, today announced plans to further test the antiviral activity of stenoparib, its PARP inhibitor, against SARS-CoV-2 lineage B.1.1.7, also known as Coronavirus Variant B117 (the "British variant"), at the COVID-19 Testing Service Center (CTSC) of Northern Arizona University's Pathogen and Microbiome Institute (PMI), a leading U.S. infectious disease testing center.

27 Jan 2021

Eviction moratoria and relief from utility disconnections reduce COVID-19 cases

Policies that helped financially struggling Americans stay in their homes and keep access to water and electricity during the COVID-19 pandemic also helped reduce the spread of the virus, according to a new analysis by Duke University researchers.

27 Jan 2021

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

The Association for Molecular Pathology (AMP), the premier global, molecular diagnostic professional society, today announced the formation of the AMP COVID Response (ACR) Steering Committee to help coordinate and communicate the organization's continued efforts to guide diagnostic testing during the ongoing COVID-19 pandemic and preparations for future emerging outbreaks.

27 Jan 2021

Higher minimum wage will reduce infant deaths, shows study

As President Joe Biden seeks to raise the federal minimum wage, a new study published recently by researchers from Syracuse University shows that a higher minimum wage will reduce infant deaths.

27 Jan 2021

Study: Use of online messaging and social media apps spiked during COVID-19 pandemic

The use of online messaging and social media apps among Singapore residents has spiked during the COVID-19 pandemic, a Nanyang Technological University, Singapore (NTU Singapore) study has found.

27 Jan 2021

Professor from Tel Aviv University receives 2021 Blavatnik Award for Young Scientists in Israel

Professor Yossi Yovel, Associate Professor of Zoology at Tel Aviv University (TAU), is one of three Laureates to be awarded 2021 Blavatnik Awards for Young Scientists in Israel by the Blavatnik Family Foundation, the New York Academy of Sciences, and the Israel Academy of Sciences and Humanities.

27 Jan 2021

SARS-CoV-2 spike may impair antigen presentation by CD8 T cells

A new study published on the bioRxiv preprint server aims to identify specific viral epitopes on the spike protein from various regions of the spike protein and the T cell responses they evoke.

27 Jan 2021

Looming eviction crisis may put Californians at increased risk for unmet medical needs

Research published in the peer-reviewed Journal of General Internal Medicine found that Californians who had moved due to unaffordable housing are significantly more likely to report unmet medical needs compared to people with non-cost-related moves.

27 Jan 2021

Rapid transmission of N501Y variants may be due to favorable effects on host receptor binding

Now, in new research posted to the preprint server bioRxiv*, scientists use an experimental structure of the Spike RBD domain co-crystallized with part of the ACE2 receptor and several in silico methods to analyze the possible impacts of three amino acid replacements (Spike K417N, E484K, N501Y) concerning ACE2 binding.

27 Jan 2021

Cell phone data can reveal behavioral changes in people diagnosed with flu-like illness

Cell phone data that is routinely collected by telecommunications providers can reveal changes of behavior in people who are diagnosed with a flu-like illness, while also protecting their anonymity, a new study finds.

26 Jan 2021

Pandemic News and Research

Further Reading

Study uncovers a novel promising target for diabetes treatment

New model could help clinicians to safely allow two patients to share a single ventilator

COVID-19 mortality rates higher in pregnant women than in similarly aged individuals

Anakinra shows therapeutic potential in critically ill COVID-19 patients

CDC researchers back U.S. school re-openings but with strict COVID-19 regulations

COVID-19 will impact cardiovascular disease deaths for years to come, warn experts

Could spironolactone treat COVID-19-related pneumonia and pulmonary fibrosis?

Remdesivir, given to half of hospitalized covid patients in U.S., is big win for Gilead — boosted by taxpayers

What do we know about the SARS-CoV-2 vaccines so far?

Purdue University-affiliated startup receives NSF grant to study severe COVID-19 cases

Allarity Therapeutics announces plans to test antiviral activity of stenoparib drug

Eviction moratoria and relief from utility disconnections reduce COVID-19 cases

New ACR Steering Committee established to guide diagnostic testing during COVID-19 pandemic

Higher minimum wage will reduce infant deaths, shows study

Study: Use of online messaging and social media apps spiked during COVID-19 pandemic

Professor from Tel Aviv University receives 2021 Blavatnik Award for Young Scientists in Israel

SARS-CoV-2 spike may impair antigen presentation by CD8 T cells

Looming eviction crisis may put Californians at increased risk for unmet medical needs

Rapid transmission of N501Y variants may be due to favorable effects on host receptor binding

Cell phone data can reveal behavioral changes in people diagnosed with flu-like illness

Best practices - optimize qPCR processes for pathogen detection eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News